Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Infect Control Hosp Epidemiol ; 39(9): 1049-1057, 2018 09.
Article in English | MEDLINE | ID: mdl-30037355

ABSTRACT

OBJECTIVE: To determine the efficacy in eradicating Staphylococcus aureus (SA) carriage of a 5-day preoperative decolonization bundle compared to 2 disinfectant soap showers, with both regimens self-administered at home. DESIGN: Open label, single-center, randomized clinical trial. SETTING: Ambulatory orthopedic, urologic, neurologic, colorectal, cardiovascular, and general surgery clinics at a tertiary-care referral center in the United States.ParticipantsPatients at the University of Minnesota Medical Center planning to have elective surgery and not on antibiotics. METHODS: Consenting participants were screened for SA colonization using nasal, throat, axillary, and perianal swab cultures. Carriers of SA were randomized, stratified by methicillin resistance status, to a decolonization bundle group (5 days of nasal mupirocin, chlorhexidine gluconate [CHG] bathing, and CHG mouthwash) or control group (2 preoperative showers with antiseptic soap). Colonization status was reassessed preoperatively. The primary endpoint was absence of SA at all 4 screened body sites. RESULTS: Of 427 participants screened between August 31, 2011, and August 9, 2016, 127 participants (29.7%) were SA carriers. Of these, 121 were randomized and 110 were eligible for efficacy analysis (57 decolonization bundle group, 53 control group). Overall, 90% of evaluable participants had methicillin-susceptible SA strains. Eradication of SA at all body sites was achieved for 41 of 57 participants (71.9%) in the decolonization bundle group and for 13 of 53 participants (24.5%) in the control group, a difference of 47.4% (95% confidence interval [CI], 29.1%-65.7%; P<.0001). CONCLUSION: An outpatient preoperative antiseptic decolonization bundle aimed at 4 body sites was significantly more effective in eradicating SA than the usual disinfectant showers (ie, the control).Trial RegistrationClinicalTrials.gov identifier: NCT02182115.


Subject(s)
Anti-Infective Agents, Local/therapeutic use , Baths , Disinfection/methods , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Soaps , Surgical Wound Infection/prevention & control , Administration, Intranasal , Adult , Aged , Carrier State/microbiology , Chlorhexidine/analogs & derivatives , Chlorhexidine/therapeutic use , Female , Humans , Logistic Models , Male , Middle Aged , Minnesota , Mouthwashes/administration & dosage , Mupirocin/therapeutic use , Nasal Cavity/microbiology , Patient Care Bundles , Preoperative Care/methods , Self Administration , Staphylococcal Infections/diagnosis , Staphylococcal Infections/drug therapy , Surgical Wound Infection/microbiology , Tertiary Care Centers
SELECTION OF CITATIONS
SEARCH DETAIL